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Abstract
Purpose: To investigate the impact of respiratory motion in the treatment margins
for lung SBRT frameless treatments and to validate our treatment margins using 4D
CBCT data analysis.
Methods: Two hundred and twenty nine fractions with early stage NSCLC were ret-
rospectively analyzed. All patients were treated in frameless and free breathing con-
ditions. The treatment margins were calculated according to van Herk equation in
Mid-Ventilation. For each fraction, three 4D CBCT scans, pre- and postcorrection,
and posttreatment, were acquired to assess target baseline shift, target localization
accuracy and intra-fraction motion errors. A bootstrap analysis was performed to
assess the minimum number of patients required to define treatment margins.
Results: The retrospectively calculated target-baseline shift, target localization accu-
racy and intra-fraction motion errors agreed with the literature. The best tailored
margins to our cohort of patients were retrospectively computed and resulted in
agreement with already published data. The bootstrap analysis showed that fifteen
patients were enough to assess treatment margins.
Conclusions: The treatment margins applied to our patient’s cohort resulted in good
agreement with the retrospectively calculated margins based on 4D CBCT data.
Moreover, the bootstrap analysis revealed to be a promising method to verify the
reliability of the applied treatment margins for safe lung SBRT delivery.
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1 | INTRODUCTION
The application of the Stereotactic Body Radiation Therapy (SBRT)
to the lung is a complicated scenario because respiratory-induced
tumor motion has an impact on the target localization and thus influ-
ences the accuracy of imaging, treatment planning, and treatment
delivery.1 One way to reduce these uncertainties is to use a respira-
tory-correlated CT scan (4D CT)2–7 at the treatment preparation
stage and to perform 4D cone beam CT (4D-CBCT) prior to treat-
ment, as both techniques provide 3D images at multiple phases of
the respiratory cycle. For lung SBRT in free breathing conditions, a
moving organ can be treated using the Mid-Ventilation approach
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(Mid-V),8,9 in which the predominant breathing phase closest to the
time-weighted mean tumor position is selected for the planning, thus
ensuring small treatment margins. However, when calculating dose
and appropriate margins for lung SBRT, motion, baseline shifts and
low-density media must also be considered. Van Herk et al.10 pro-
posed a probabilistic approach to create the margins. The key of this
approach is to include the systematic and random errrors based on
clinical practice when computing the margins, in order to ensure
adequate tumor dose coverage for a high percentage of patients.
The systematic and random errors for lung tumors can be defined by
statistical analysis of the distribution of changes in tumor position
during a course of radiotherapy. Therefore, the 4D CBCT11 makes it
possible to assess, prior to each fraction treatment, the mean posi-
tion and the 3D trajectory of the tumor, and then to verify the
applied treatment margins on a daily basis. Moreover, breathing-re-
lated variations in tumor positions can appear during the treatment
intra- and inter-fractionally. The intra-fraction variation describes the
variation in the tumor position during one treatment fraction,12–14
while the inter-fraction variation describes the variation of the tumor
position between fractions. These two types of tumor motion varia-
tions are mainly manifested as tumor baseline shifts and introduce
additional errors in the treatment. For this reason, 4D CBCT images
taken at different moments in the treatment session are an appropri-
ate way to quantify such errors; they also allows to track the 3D tra-
jectory of the tumor, therefore veryfing the applied treatment
margins on a daily basis. Within this context, the van Herk approach
is commonly used to prospectively define setup margins for lung
SBRT. However, this approach relies on statistical analysis of
prospective data, assuming that no changes in the process occurs in
the future. In this paper we propose two approaches that proactively
re-examines the margins when the process is changed by a modifica-
tion in contention, treatment technique, etc. In those cases, it is
indeed crucial to verify the applied margins to ensure safe SBRT
delivery.
2 | MATERIAL AND METHODS
2.A | Patients
Thirty patients (for a total of 229 fractions) with lower (n = 6), upper
(n = 9) and mid-lobe lesions (n = 15) and stage T1-T2 nonsmall-cell
lung cancer were treated with SBRT. For each patient, a planning CT
was acquired (16-slices Aquilion LB; Toshiba, Japan) using a 4D
acquisition protocol. Ten respiratory phases were retrospectively
reconstructed from the 4D CT with the phase sorting algorithm. All
patients were scanned in head-first supine position using an arm and
knee support. No additional immobilization devices were used, and
none of the patients received any instructions for regular breathing
before scan and treatment. The tumor motion characteristics,
described as amplitude and trajectory, were assessed in the three
directions. To determine the Mid-V phase, 10 GTVs were contoured
on the ten phases and the center of the mass of the GTV was deter-
mined for each phase. The phase providing the minimum distance
between the center of mass of the GTV on each phase and the aver-
age center of mass of the GTV among the ten phases was selected
as the Mid-V phase. Once the Mid-V9 phase was identified then it
was used for the delineation of the tumor and organs at risk as well
as treatment planning. The patient-specific tumor motion characteris-
tic was used to calculate planning target volume (PTV) margins, with
the van Herk equation.10
2.B | Target volumes and planning
The Gross Target Volume (GTV) was delineated on the Mid-V phase,
in the Velocity software™ version 2.8 (Varian Medical Systems,
USA), using a pulmonary level window (WW: 1224; WL: −412). No
margins for microscopic extension were added to the GTV to form a
Clinical Target Volume (CTV).15 The PTV was created by applying
margins to the GTV based on the van Herk equation10 (see Margins
section). The fractionation schemes were 12 x 5 Gy (n = 3),
5 × 12 Gy (n = 6), 8 × 7.5 Gy (n = 20) and 3 × 18 Gy (n = 1)
depending on the tumor size and localization. All patients were
planned with MONACO Monte Carlo-based Treatment Planning Sys-
tem (TPS) (Elekta, Sweden) for Volumetric Modulated Arc Therapy
(VMAT) delivery. Plans were prepared for a single arc or two arc
VMAT deliveries depending on the patient anatomy.
2.C | Target motion assessment
Target motion amplitude was individually quantified for all patients
before the start of the treatment (Table 1). The amplitude of the tar-
get measured from the 4D CT was defined as the maximum coordi-
nates minus the minimum coordinates of the target centroid in the
left-right (LR), cranial-caudal (CC), and anterior-posterior (AP) direc-
tions. The 3D scalar amplitude was defined as the distance in 3D




. The 4D CT parame-
ters were 120 kV, 150 mA, a detector width of 320 mm and a rota-
tion time of 0.5 seconds. The pitch was less than 0.1 in order to
ensure that at least one complete respiratory cycle was included in
the scan acquisition.16 Images were reconstructed with 2 mm slice
thickness and 2 mm slice separation. The respiratory signal was
tracked with the AZ-733 V ANZAI belt (ANZAI Medical Solutions,
Japan) measuring the variation of pressure on the belt generated by
the breathing motion. Ten respiratory breathing phases were sorted
retrospectively.
2.D | On-line 4D CBCT for target localization and
motion characterization
Image Guided Radiotherapy (IGRT) and treatment were performed
on an Elekta Synergy linear accelerator with integrated CBCT scan-
ner (Elekta, Sweden). Each patient was positioned with the arm and
knee support used for the planning CT and aligned to the room
lasers. A pretreatment 4D CBCT17 scan was acquired. The average
4D CBCT was registered to the primary image Mid-V using XVI soft-
ware v 4.5 (Elekta, Sweden); an automatic rigid registration of the
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bony anatomy (i.e. vertebrae) and of the GTV (soft-tissue) with an
expansion of 5 mm was chosen in order to create a 3D shape of the
region of interest (ROI). That ROI was automatically registered to
each phase of the 4D CBCT. The goal was to verify that the overall
tumor motion excursion measured on the ten phases was within the
PTV margins applied on the Mid-V phase. In case a shift was
detected, only the translation corrections relative to the GTV isocen-
ter were applied to the couch, because rotation corrections were
not supported by our treatment couch. A second 4D CBCT was
acquired after couch correction to assess the residual setup errors.
Again, a dual automatic registration of both bony anatomy and ROI
was performed in order to visually validate the target alignment. A
posttreatment 4D CBCT scan was acquired at the end of the treat-
ment delivery to quantify the intra-fraction motion errors, obtained
as the difference in target alignment between the second and the
third 4D CBCT scan. To reduce the additional dose to the patient,
the first 4D CBCT was acquired with the standard protocol of
4 minutes, while the second 4D CBCT was reduced to 2 minutes by
downsizing the number of projections and the final 4D-CBCT to only
1 minute. The resulting image quality was good enough to evaluate
the intra-fraction motion errors.18 Finally, the 3D couch shifts from
the three 4D CBCTs using soft-tissue and bony registration were
collected for all treatment fractions and for all patients and used to
retrospectively determine the margins according to our data as
described in the Margins section.
2.E | Margins
The 3D couch shifts using soft-tissue and bony registration were col-
lected for all treatment fractions for all patients. The mean and stan-
dard deviation were calculated for each patient. From these data, the
standard deviation of the systematic error (∑), and standard deviation
of the random error (σ) were calculated. The ∑ was obtained by calcu-
lating the standard deviation of the mean for each patient, and the σ
was the root mean square of the standard deviations for each patient.
To analyze the difference between the bony and soft-tissue registra-
tion, the couch shifts obtained using soft-tissue registration were sub-
tracted from the couch shifts obtained using bony registration in each
direction. Finally, the PTV margins, M(PTV), for frameless SBRT
patients with online 4D CBCT image guidance were calculated for






where ∑TOT and σTOT are the overall systematic and random errors
(as defined in Equations 2 and 3)19 and σp is the width of the






Sum of the standard deviations of the systematic errors calcu-






Sum of the root mean square of the random errors calculated
from localization, intra-fraction and respiratory motion.
For the lung, σp was taken equal to 0.64 cm as analytically esti-
mated by Mexner et al.20 Equation 1 describes the GTV to PTV mar-
gin necessary to ensure that the GTV receives 99 % of the
prescribed dose for 90 % of the patients when all geometric uncer-
tainties are included. The target delineation error (1 SD = 2 mm for
T1-T2 tumor staging),21,22 the target localization error and the intra-
fraction motion error were considered as systematic errors. The lat-
ter comes from the fact that the treatment lasts longer than the
planning CT and therefore the free breathing of the patient causes a
deviation in the shape of the total dose distribution. For each patient
the respiratory motion error is calculated according to the Lujan
equation.23 The margins used for the patients treatment were
TAB L E 1 Target motion amplitude at 4D CT.
# Patient LR [cm] AP [cm] SI [cm] 3D [cm]
1 0.2 0.2 0.06 0.29
2 0.21 0.43 0.37 0.6
3 0.09 0.46 1.32 1.4
4 0.04 0.14 0.55 0.57
5 0.12 0.25 1 1.04
6 0.4 0.39 0.2 0.59
7 0.12 0.23 0.1 0.28
8 0.1 0.19 0.27 0.34
9 0.11 0.22 0.2 0.32
10 0.26 0.26 0.12 0.39
11 0.11 0.34 0.8 0.88
12 0.32 0.21 0.2 0.43
13 0.12 0.38 0.2 0.45
14 0.25 0.51 0.4 0.69
15 0.13 0.27 0.2 0.36
16 0.21 0.32 0.67 0.77
17 0.28 0.37 0.3 0.55
18 0.65 0.64 0.4 1
19 0.22 0.23 0.35 0.47
20 0.09 0.22 1.39 1.41
21 0.1 0.2 0.33 0.4
22 0.11 0.33 1.2 1.25
23 0.28 0.26 0.6 0.71
24 0.1 0.2 1.18 1.2
25 0.22 0.21 1.2 1.24
26 0.21 0.11 2.2 2.21
27 0.59 0.19 0.08 0.62
28 0.43 0.21 0.6 0.77
29 0.16 0.17 0.26 0.35
30 0.28 0.25 0.34 0.51
Abbreviations: AP, Anterior-Posterior target motion amplitude; LR, Left-
Right target motion amplitude; SI, Superior-Inferior target motion ampli-
tude.
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initially taken from the data of systematic and random errors
reported in the literature17 (target localization accuracy, intra-fraction
motion and target delineation uncertainty, intra-fraction motion and
respiratory motion, see Table 2). Then the errors obtained from the
retrospective analysis of the patients treated at our institution were
used to compute customized margins.
2.F | Iterative analysis
To assess the robustness of our data, the margins were recalculated
with an iterative method for different subsets of 10, 15, 20, 25 and
30 patients taken in chronological order (p + 1) with respect to their
treatment. The scope was to determine whether or not the margins
calculated were converging for samples with increasing number of
patients. This approach has been chosen at first due to its rather
simple implementation; however it presents a major drawback, the
lack of large data to build good statistics. This was a clear limitation
to validate our results.
2.G | Bootstrap analysis
The principle of the bootstrap method is that inference regarding a
population can be modeled by resampling with replacement a subset
of this population.24,25 In this way, it is possible to expand the sam-
pling from a limited pool of data and better estimate the statistical
parameters of the population. In particular, for each patient error
(target localisation accuracy, intra-fraction motion, and target delin-
eation), a resampling was computed with different cohort sizes to
create new systematic and random errors. For the bootstrap calcula-
tion the delineation systematic error was fixed at 2 mm for all
patients. The localization systematic error was defined as: Σloc = SD
(M(p)) where SD represents the standard deviation, M represents the
mean, and p represents the pth patient. The pth is a patient created
from a resampling with replacement of the localization patient’s data
of one patient randomly chosen. The intra-fraction systematic error
was defined as Σintra = SD (M(s)) where s represents the sth session.
The sth is a session created from a resampling with replacement of
the intra-fraction patient’s data of n patients randomly chosen.
The motion amplitude random error was fixed at 0.36 x patient’s






where n represents the number of patient and p rep-
resents the pth patient. Finally, the intra-fraction random error was





where n represents the number of
patient and s represents the sth session.
In our experiment, the cohort size was defined by the number of
patients n included in this cohort with n equal to
3,6,9,12,15,30,50,75,100 and 150. For each sampling, bootstrap cal-
culation was repeated 1000 times with random choice of patients at
each time. The mean and standard error was calculated from the
results obtained with these 1000 repetitions.
3 | RESULTS
3.A | Target motion
Figure 1 shows the relation of the target motion between 4D CT
and the first 4D CBCT in the three directions. The correlation coeffi-
cient was R2 = 0.96 in the LR and SI directions, and R2 = 0.92 in
the AP direction.
3.B | Error analysis
Figure 2 shows the histograms obtained from the analysis of the tar-
get baseline shift, the target localisation, and the intra-fraction motion
errors on the 229 fractions, in the three directions. The mean and
standard deviation of the target baseline shift were 0.00  0.16 cm,
0.02  0.25 cm and 0.01  0.22 cm for LR, AP, and SI directions,
respectively. The mean and standard deviation of the target localiza-
tion were −0.01  0.16 cm, −0.11  0.21 cm and 0.06  0.21 cm
for LR, AP and SI directions, respectively. The mean and standard devi-
ation of the intra-fraction were −0.00  0.17 cm, −0.02  0.18 cm,
and 0.01  0.15 cm for LR, AP and SI directions, respectively.
3.C | Margins computation
As expected,26,27 the systematic errors are dominated by the delin-
eation error (Table 2). All errors used for treatments (data from
TAB L E 2 Systematic and random errors of van Herk equation for
margins calculation based on the off-line analysis (4D CBCT data)
and from literature (treatment); the latter was taken as reference. A
is the target motion amplitude.
LR (cm) AP (cm) SI (cm)
Systematic errors ∑e
Localisation
Off-line 0.09 0.15 0.12
Treatment 0.08 0.09 0.08
Delineation
Off-line 0.2 0.2 0.2
Treatment 0.2 0.2 0.2
Intra-fx
Off-line 0.03 0.07 0.12
Treatment 0.12 0.18 0.12
Random errors σe
Localisation
Off-line 0.14 0.15 0.2
Treatment 0.11 0.14 0.11
Target motion
Off-line 0.36xA(LR) 0.36xA(AP) 0.36xA(SI)
Treatment 0.36xA(LR) 0.36xA(AP) 0.36xA(SI)
Intra-fx
Off-line 0.14 0.15 0.22
Treatment 0.13 0.18 0.15
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literature) were in general smaller than the ones calculated retro-
spectively (off-line analysis) with the exceptions of the intra-fraction
in the LR and AP directions for the systematic error and AP direction
for the random error (Table 2).
Figure 3 shows the PTV margins based on published data and
off-line data from 30 patients treated at our center. The margins cal-
culated with off-line data were systematically larger than those com-
ing from the literature.
3.D | Iterative analysis
The margins calculated with the iterative analysis using different
subsets of patient samples are reported in Figure 4, along with their
corresponding standard error. An asymptotic margin reduction trend
is observed as the number of patients involved in the calculation
increases.
3.E | Bootstrap
Figure 5 shows the results of the margins calculated applying the
bootstrap method for different simulations (number of included
patients being 3, 6, 9, 12, 15, 30, 50, 75, 100 and 150), along with
their standard errors. We did not observe any statistical difference
on the calculated margins for cohort sizes including more than 15
patients.
4 | DISCUSSION
The aim of our study was to provide centers, which are either imple-
menting frameless lung SBRT or still using literature margins, a
method to calculate personalized margins. The method proposed in
this paper takes into account changes in the process due to
F I G . 1 . Correlation between 4D CT and
4D CBCT target motion displacement in all
directions. The dashed-dotted line
corresponds to a unity fit.
F I G . 2 . Histograms of the target baseline-shift (left), target localization accuracy (centre), and intra-fraction motion (right), in the three
directions. The solid curves represent a gaussian fit of the data.
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modification of contentions, treatment technique, etc. In those cases,
it is crucial to verify the applied margins to ensure continued safe
SBRT delivery. We therefore retrospectively analyzed our patient
cohort to assess the margin uncertainties induced by respiratory
motion during frameless stereotactic radiotherapy, and then com-
pared them with already published data. We also determined the
minimum number of patients required to validate our treatment mar-
gins based initially on literature data with an iterative method and a
bootstrap method. The bootstrap method performed better than the
iterative method. The former having larger data than the latter was
capable to provide better statistics and so to better converge.
At first, we assessed the target motion excursion for each patient
by analysing 4D CT data. As expected, we found that the most
important motion was in the superior-inferior direction, with a maxi-
mum tumor motion of 2.2 cm, in agreement with other authors.13,14
The tumors located in the lower lobe were the most impacted by
the large motion amplitude, while the upper and median lobes were
giving similar results. In this specifc case, the reliability of the frame-
less approach with respect to the breathing managing technique
might be questionable. However, in our cohort we found only one
patient where the motion amplitude was superior to 2 cm that
would have justified the benefit of using breathing management
technique. Moreover, we found a correlation between motion excur-
sion detected in the 4D CT and in the 4D CBCT data, with a correla-
tion coefficient of R2 = 0.96 in the LR and SI directions, and
R2 = 0.92 in the AP direction. The observed differences may be due
to the different techniques used for phase sorting, i.e belt for 4D CT
and diaphragm motion for 4D CBCT. Nevertheless, the respiratory
motion assessed from the 4D CT scan was mostly reproducible dur-
ing the treatment delivery for our patient cohort (see Figure 1).28–31
As also found in a recent paper of Liang et al.32 if the baseline shift
can be corrected by treatment couch, the target motion range is
F I G . 3 . PTV margins calculated according to the off-line analysis
(4D CBCT data; filled marker) and from treatment (literature data;
empty marker), in the three directions and for the 30 patients,
respectively. Abbreviations: LR, Left-Right; AP, Anterior -Posterior;
SI, Superior-Inferior.
F I G . 4 . Margins calculated from the off-line analysis (4D CBCT
data) for a different number of patients. The error standard bars for
each data are also shown in the graph. Abbreviations: LR, Left-Right;
AP, Anterior -Posterior; SI, Superior-Inferior.
F I G . 5 . PTV margins calculated from the bootstrap analysis on the
4D CBCT data, in the three directions and for the 3 to 150
bootstrap simulations according to different initial patient sample
sizes, 10, 15, 20 and 28, taken consecutively. The standard error
bars for each data are also shown in the graph. Abbreviations: LR,
Left-Right; AP, Anterior -Posterior; SI, Superior-Inferior.
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comparable to the one assessed with the 4DCT. Regarding the use
of the 4D CBCT, it should be noted that for an ITV approach, the
3D CBCT alone may be sufficient since the blurred target volume on
the 3D CBCT can be associated to an ITV; however for a Mid-V
approach, a 4D CBCT is highly recommended as confirmed by
others.33–35 From the retrospective 4D CBCT data analysis, we
observed that the target delineation was the largest error as was
found by others.26,27 It is well-known,10 that this systematic error
has a big impact on the margin definition. Unfortunately, this error
was not assessed in this study as well as the sigma penumbra and
we consider those two as limitations of the study. From the analysis
of the target baseline shift, the target localization, and the target
intra-fraction motion we found, in all directions, mean values of max-
imum 0.2 mm and standard deviations of maximum 2.5 mm. This
indicates the robustness of the Mid-V strategy associated with the
van Herk equation (see Figure 2). The larger systematic errors found
for the AP target localization are probably caused by the patient
relaxing between the first and second 4D CBCT. The values
obtained for the systematic and random localization errors, i.e., dis-
crepancies between planned and actual tumor position after correc-
tions have been applied, were comparable to what was found by
Sonke et al.17 However, the applicability of the van Herk equation in
the context of SBRT might be still questioned. Within this context,
Ecclestone et al.36 have recently investigated the robustness of the
van Herk equation to variation in tumor size, motion amplitude, tis-
sue density and plan technique in lung radiotherapy and they
ensured the safe clinical application of the van Herk margins as no
CTV under dosage was observed. Another aspect to consider in the
van Herk equation is the difference of the number of fractions for
SBRT over standard radiotherapy treatment. For this reason as
reported by Leong et al.37 and van Herk et al.38 in Equation 1 an
additional systematic error was taken into account, being the quad-
ratic sum of the random errors divided by the square root of the
number of fractions. Moreover, Sonke et al.17 suggested that if the
errors are quantified from a limited number of fractions, this effect
will be implicitly taken into account when calculating margins. There-
fore, the above considerations justify the application of the van Herk
equation to the Mid-V approach for safe lung SBRT. In particular,
the Mid-V approach minimizes some of those systematic errors, such
as target localization and baseline shifts errors, hence reducing the
margins size for a better sparing of the organs at risk. It should be
noted that mid-position, a refinement of the Mid-V concept, would
have even more improved the image quality by means of artifacts
reduction as described by Wolthaus et al.39 thus providing a better
representation of the tumor shape and volume. However, this
approach is more complex and time consuming since it requires a
reliable deformable image registration tool. Nevertheless, Peulen
et al.40 have reported an excellent local control of 98% using the
Mid-V based PTV margin approach combined with online image
guided SBRT in early stage lung cancer.
Senthi et al.41 have reported in their sytematic review low level
of toxicity with SBRT, offering a safe and effective curative treat-
ment for patients with central tumors who unfit for surgery. In
Figure 3 was shown the comparison between the applied systematic
and random errors obtained from the literature (treatment) and the
systematic and random errors calculated retrospectively from the 4D
CBCT (off-line analysis). The comparison illustrated that the treat-
ment margins were systematically larger in all directions with the lar-
gest difference of about 1 mm in the SI direction. Our results seem
to indicate that margins calculation depends on the local parameters
of the patient cohort, treatment technique and immobilization sys-
tem as described by Lin et al.42 and that the parameters used in the
literature may not be used locally without caution. In other terms,
data from the literature might be taken as a starting point, but the
margins applied to patients should be re-evaluated with local results
obtained through acquired experience (i.e. patient treatments). Not
performing that local evaluation could lead to overly large margins
that might, in certain cases, be clinically unacceptable for lung
stereotactic treatments. For this reason, to assess the robustness of
our results and to determine the minimum number of patients
required to validate custom margins, the latters were calculated
using first an iterative method. As shown in Figure 4, the results did
not converge for 30 patients; in particular, a monotone decreasing
function with associated large errors bars was observed. As a conse-
quence, the bootstrap method was chosen, providing more statistics.
This method was recently implemented in radiation oncology to esti-
mate toxicity, setup errors, organ motion, or in other applica-
tions43,44, but it was never applied to the context of margin
validation. The analysis showed that, independently from the initial
patient sample size, a sample of at least 15 patients was needed to
observe a convergence (see Figure 5). This is in agreement with a
similar study conducted by Matsumoto et al.45 Chaikh et al.46 where
they also reported that the bootstrap method can be considered as
a practical solution to simulate a larger population in case of a small
sample size. In their paper, the authors recommended the use of the
bootstrap for a sample size larger than 10 to provide good estima-
tion in case of heterogeneous and not normally distributed data. The
main difference between the iterative and bootstrap methods is that
with the iterative method we can only extrapolate the data to obtain
the correct margins, while it is possible with the bootstrap method
to reach a convergence (plateau in Figure 5) with at least 10
patients,28 and so to define the correct margins in each direction.
A limitation of this study is that rotational errors were not taken
into account in the margins computation, because our linear acceler-
ator was not equipped with a 6 degrees of freedom (DOF) couch.
However, in our study we did not observe rotation angles larger
than 1°. Besides, it is important to notice that the lung SBRT tumors
are generally small and spherical in shape; thereby the value of rota-
tional shifts is further minimized, by placing the isocenter within the
GTV. Indeed, as found by Ottoson et al.47 CTV to PTV margins were
approximately the same, regardless if the CBCT matches were per-
formed with 3 or 6 DOF. Finally a robotic couch wouldn’t lead to
further margin reduction.
If we now consider the impact of the type of technique VMAT
or IMRT to the margins, in the publication of Rana et al.48 it has
been shown that the major advantage of VMAT over IMRT is in the
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reduction of the number of monitor units leading to a faster treat-
ment delivery times without compromising the quality of the treat-
ment plans. Hence, faster delivery time is more patient-friendly and
minimizes intra-fraction patient motion enabling the reduction of the
treatment margins.49,50 In line with this study, in our center all SBRT
are delivered with VMAT technique.
5 | CONCLUSIONS
The study presented here is a retrospective margins analyisis col-
lected on a group of patients. We believe that this analysis could be
beneficial to centers that want to apply personalized margins or sim-
ply adapt their margins.
The minimum number of patients needed to reach a convergence
in the margin definition was evaluated using both iterative and boot-
strap methods. The two methods provided similar results within the
uncertainties. However, the iterative method was not converging
because the number of patients of our cohort was not enough to
reach conclusions on the margins. On the contrary, the bootstrap
method showed that the required patient sample size to validate our
treatment margins for frameless lung SBRT on a population scale
was 15 patients.
To conclude, when implementing lung SBRT treatments, or when
adapting the lung SBRT treatment protocol due to changes in local
practice, an analysis based on the bootstrap method is suggested to
verify the safe delivery of the treatment, without adding extra dose
to the patient and increasing the treatment time.
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